Evidence map›Paper›PMID 37006360›Full record

ArticleRSC advances2023

Multi-enzyme catalysed processes using purified and whole-cell biocatalysts towards a 1,3,4-substituted tetrahydroisoquinoline.

Douglas Weber, Lucas de Souza Bastos, Margit Winkler, Yeke Ni, Abil E Aliev, Helen C Hailes, Doerte Rother

Abstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. A Cholesterol Analogue for Cell-Surface Enzyme Display.Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Douglas WeberInstitute of Bio- and Geosciences (IBG-1): Biotechnology, Forschungszentrum Juelich GmbH 52425 Juelich Germany do.rother@fz-juelich.de.ORCID https://orcid.org/0000-0002-8668-2721
Lucas de Souza BastosInstitute of Bio- and Geosciences (IBG-1): Biotechnology, Forschungszentrum Juelich GmbH 52425 Juelich Germany do.rother@fz-juelich.de.
Margit Winkleracib GmbH Krenngasse 37 A-8010 Graz Austria.ORCID https://orcid.org/0000-0002-0754-9704
Yeke NiDepartment of Chemistry, University College London London WC1H 0AJ UK.
Abil E AlievDepartment of Chemistry, University College London London WC1H 0AJ UK.
Helen C HailesDepartment of Chemistry, University College London London WC1H 0AJ UK.ORCID https://orcid.org/0000-0001-5574-4742
Doerte RotherInstitute of Bio- and Geosciences (IBG-1): Biotechnology, Forschungszentrum Juelich GmbH 52425 Juelich Germany do.rother@fz-juelich.de.ORCID https://orcid.org/0000-0002-2339-4431

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, two multi-enzyme catalysed processes to access a 1,3,4-substituted tetrahydroisoquinoline (THIQ), using either purified enzymes or lyophilised whole-cell catalysts, are presented. A key focus was the first step in which the reduction of 3-hydroxybenzoic acid (3-OH-BZ) into 3-hydroxybenzaldehyde (3-OH-BA) was catalysed by a carboxylate reductase (CAR) enzyme. Incorporation of the CAR-catalysed step enables substituted benzoic acids as the aromatic components, which can potentially be obtained from renewable resources by microbial cell factories. In this reduction, the implementation of an efficient cofactor regeneration system of both ATP and NADPH was crucial. Two different recycling approaches, either using purified enzymes or lyophilised whole-cells, were established and compared. Both of them showed high conversions of the acid into 3-OH-BA (>80%). However, the whole-cell system showed superior performance because it allowed the combination of the first and second steps into a one-pot cascade with excellent HPLC yields (>99%, enantiomeric excess (ee) ≥ 95%) producing the intermediate 3-hydroxyphenylacetylcarbinol. Moreover, enhanced substrate loads could be achieved compared to the system employing only purified enzymes. The third and fourth steps were performed in a sequential mode to avoid cross-reactivities and the formation of several side products. Thus, (1

Identifiers

PMID37006360
PMCPMC10053099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.